A study on iluppai ennai in the management of kaduvan

A pilot study on clinical evaluation of siddha herbal formulation Iluppai Ennai( External Medicine) in the management of Kaduvan(Lichen Planus) among out-patients attending the OPD of ayodhidass pandithar hospital, National Institute of siddha. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080869

Enrollment

Registered

2025-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L439- Lichen planus, unspecified

Interventions

Intervention1: Iluppai ennai: External application of the medicine 30 ml for 1 week 2 times a day Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Age: 30 to 60 years Gender: Male/Female/Transgender Patients having the signs and symptoms of kaduvan (lichen planus) and LPSI score below 53 Purple polygonal planar pruritic papules plaques. Patients willing and able to provide informed consent and to comply with the study protocol.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women. Known cases of Skin diseases [contact dermatitis, vitiligo, psoriasis, atopic dermatitis]. Other diseases or medications that might directly interfere in the study.

Design outcomes

Primary

Measure	Time frame
Reduction in LICHEN PLANUS SEVERITY INDEX Score will be assessed before and after treatment period.Timepoint: 2 months - Screening 2 months - Patient enrollment 2 months - outcome assessment	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactSuruthi Balakrishnan

National Institute of Siddha

drmanjarimd@gmail.com8056903083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026